CN Stock MarketDetailed Quotes

301096 Hangzhou Bio-Sincerity Pharma-Tech

Watchlist
  • 39.77
  • +0.07+0.18%
Market Closed Dec 27 15:00 CST
4.34BMarket Cap20.48P/E (TTM)

Hangzhou Bio-Sincerity Pharma-Tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-73.62%242.99M
-42.96%615.45M
-38.33%790.56M
-28.81%881.93M
-31.34%921.14M
-28.91%1.08B
-21.56%1.28B
-38.46%1.24B
751.41%1.34B
1,658.25%1.52B
Transactional financial assets
--219M
--83.66M
----
----
----
----
----
----
----
----
Notes receivable and accounts receivable
93.97%396.77M
77.38%357.94M
31.03%252.88M
40.39%213.2M
78.90%204.55M
138.22%201.79M
91.45%193M
96.69%151.87M
70.73%114.34M
40.44%84.71M
-Notes receivable
-32.48%6.95M
-21.23%3.96M
0.24%4.46M
464.54%13.28M
219.44%10.3M
23.32%5.03M
304.29%4.45M
416.01%2.35M
-7.12%3.22M
-33.95%4.08M
-Accounts receivable
100.67%389.82M
79.90%353.98M
31.75%248.42M
33.71%199.92M
74.82%194.25M
144.04%196.76M
89.10%188.55M
94.79%149.52M
74.98%111.12M
48.93%80.63M
Other receivables (including interest and dividends)
-41.41%3.17M
-26.58%3.36M
-35.88%3.16M
-14.37%4.1M
14.49%5.4M
-9.09%4.57M
-1.78%4.93M
16.80%4.79M
76.06%4.72M
6.13%5.03M
-Other receivable
----
-26.58%3.36M
----
----
----
-9.09%4.57M
----
16.80%4.79M
----
6.13%5.03M
Contractual assets
77.94%437.81M
89.01%416.38M
180.08%369.74M
210.82%318.98M
148.75%246.04M
232.39%220.3M
135.18%132.01M
117.45%102.62M
156.21%98.91M
133.59%66.28M
Advance payment
32.70%66.92M
17.76%42.95M
42.72%53.52M
76.44%42.28M
89.55%50.43M
87.85%36.47M
120.10%37.5M
80.98%23.96M
103.54%26.6M
376.32%19.42M
Inventories
70.23%149.22M
67.65%152.32M
63.15%123.75M
41.06%93.17M
58.36%87.66M
119.55%90.85M
144.53%75.85M
189.04%66.05M
77.85%55.35M
360.37%41.38M
Other current assets
72.87%75.19M
66.73%62.79M
153.33%75.98M
148.18%54.12M
129.28%43.5M
205.70%37.66M
-32.94%29.99M
-54.53%21.81M
-26.99%18.97M
-62.89%12.32M
Total current assets
2.08%1.59B
3.84%1.73B
-4.87%1.67B
-0.13%1.61B
-6.13%1.56B
-4.37%1.67B
-7.08%1.76B
-27.66%1.61B
394.18%1.66B
610.13%1.75B
Non Current assets
Other non-current financial assets
2.06%132.35M
16.32%132.35M
39.09%125.51M
48.55%120.51M
577.21%129.69M
620.13%113.78M
1,403.94%90.24M
1,522.45%81.12M
283.00%19.15M
216.00%15.8M
Long-term equity investment
--17.57M
--16.43M
--16.52M
--16.36M
----
----
----
----
----
----
Long term receivable account
----
----
----
----
-2.31%1.97M
-2.21%1.95M
-2.10%1.93M
-1.99%1.91M
4.34%2.02M
4.52%2M
Fixed assets
----
58.86%1.63B
----
----
----
126.59%1.03B
----
16.75%521.61M
----
473.60%453.21M
Constru in process
----
-47.63%172.69M
----
----
----
17.19%329.74M
----
424.80%546.21M
----
-18.76%281.37M
Intangible assets
14.30%91.88M
29.39%104.83M
13.58%92.78M
11.78%92.07M
21.17%80.39M
21.02%81.02M
20.69%81.69M
35.50%82.37M
8.27%66.34M
8.76%66.94M
Long deferred expense
-91.40%53.26K
-9.14%359.66K
-89.23%176.55K
-93.82%246.59K
-93.32%619.58K
-96.44%395.85K
-87.00%1.64M
-72.31%3.99M
-40.18%9.28M
-23.65%11.13M
Deferred tax assets
-2.21%63.8M
-15.79%61.64M
-18.36%52.43M
-9.33%48.43M
56.13%65.24M
135.97%73.2M
125.96%64.22M
133.65%53.41M
174.20%41.79M
139.75%31.02M
Usufruct assets
4,971.75%3.48M
803.35%990.85K
-81.31%1.05M
-85.03%1.14M
-99.28%68.55K
-99.05%109.69K
-58.97%5.62M
-51.87%7.6M
-45.64%9.51M
-41.94%11.6M
Other non current assets
-17.17%65.71M
-31.74%57.13M
8.56%55.78M
99.75%43.14M
69.96%79.33M
289.53%83.7M
95.78%51.38M
-19.77%21.6M
76.93%46.68M
-59.34%21.49M
Total non current assets
17.40%2.17B
27.29%2.18B
45.22%2.17B
56.18%2.06B
73.90%1.85B
91.25%1.71B
104.80%1.49B
88.73%1.32B
88.28%1.06B
50.24%894.57M
Total assets
10.39%3.76B
15.71%3.91B
18.13%3.83B
25.24%3.67B
25.10%3.41B
28.01%3.38B
24.05%3.25B
0.17%2.93B
202.45%2.72B
213.94%2.64B
Liabilities
Current liabilities
Short term loan
92.55%558.82M
126.21%633.88M
153.53%634.02M
--369.32M
--290.22M
--280.21M
--250.08M
----
----
----
Transactional financial liabilities
----
----
----
----
----
----
----
----
----
--2.92M
Notes payable and accounts payable
-44.85%132.21M
-21.55%173.38M
44.88%233.87M
93.61%323.38M
252.21%239.7M
274.69%221M
211.31%161.42M
24.80%167.03M
2.88%68.06M
-50.31%58.98M
-Notes payable
-80.74%17.61M
-19.95%49.81M
177.86%100.36M
273.06%103.42M
2,372.61%91.45M
4,794.70%62.22M
802.93%36.12M
593.03%27.72M
--3.7M
--1.27M
-Accounts payable
-22.70%114.6M
-22.18%123.57M
6.55%133.52M
57.90%219.96M
130.35%148.25M
175.13%158.78M
161.86%125.31M
7.29%139.3M
-2.71%64.36M
-51.38%57.71M
Contract liabilities
2.40%92.73M
14.32%90.8M
-25.71%64.01M
18.21%74.01M
39.16%90.55M
21.79%79.42M
38.51%86.17M
-12.02%62.61M
-14.44%65.07M
28.25%65.21M
Salaries payable
-29.32%22.95M
-8.37%22.88M
29.57%22.04M
53.82%64.51M
61.10%32.47M
41.85%24.97M
54.48%17.01M
75.29%41.94M
61.67%20.15M
50.84%17.61M
Taxs payable
-66.69%9.25M
-44.19%12.6M
-26.07%7.86M
29.01%12.09M
78.43%27.75M
754.38%22.58M
310.63%10.63M
10.49%9.37M
1,332.43%15.55M
147.49%2.64M
Other payable (including interest and dividends)
211.04%5.24M
444.14%7.93M
17.39%1.22M
172.04%2.5M
105.21%1.69M
104.88%1.46M
54.47%1.04M
-20.84%918.15K
106.04%821.71K
-39.89%711.36K
-Other payable
----
444.14%7.93M
----
----
----
104.88%1.46M
----
-20.84%918.15K
----
-39.89%711.36K
Non current liabilities due within one year
297.49%706.87K
120.57%392.25K
-93.43%395.11K
-95.65%384.69K
-97.60%177.83K
-98.12%177.83K
-33.45%6.01M
-96.14%8.84M
--7.42M
--9.44M
Total current liabilities
20.42%821.9M
49.54%941.86M
80.97%963.42M
191.09%846.19M
285.46%682.56M
299.85%629.83M
281.65%532.36M
-38.50%290.7M
13.39%177.08M
-14.15%157.51M
Current liabilities
Long term loan
--40.03M
--40.02M
----
----
----
----
----
----
----
-80.93%39.25M
Estimate liabilities
16.67%91.39M
-54.26%92.19M
-48.78%89.47M
-35.64%97.17M
-37.65%78.33M
101.21%201.53M
85.18%174.66M
75.90%150.97M
121.12%125.64M
101.77%100.16M
Deferred tax liabilities
----
----
----
----
67,782.88%3.96M
69,812.92%4.1M
72,885.93%4.32M
72,977.23%4.32M
-1.39%5.83K
-0.85%5.86K
Long term deferred income
-18.42%33.43M
2,596.73%37.01M
2,697.47%39.5M
2,701.79%40.67M
--40.97M
--1.37M
--1.41M
--1.45M
----
----
Lease liabilities
--3.05M
--848.81K
382.92%913.49K
--933.05K
----
----
-96.31%189.16K
----
-84.08%2.89M
-82.20%3.6M
Total non current liabilities
36.21%167.9M
-17.84%170.07M
-28.07%129.88M
-11.46%138.78M
-4.10%123.27M
44.74%207M
29.78%180.58M
16.62%156.74M
-61.91%128.53M
-48.13%143.01M
Total liabilities
22.83%989.8M
32.87%1.11B
53.35%1.09B
120.13%984.97M
163.68%805.82M
178.45%836.83M
155.88%712.94M
-26.30%447.45M
-38.08%305.61M
-34.56%300.53M
Shareholders equity
Paid-in capital
0.98%109.23M
0.70%108.92M
0.70%108.92M
0.70%108.92M
0.00%108.17M
0.00%108.17M
0.00%108.17M
0.00%108.17M
33.33%108.17M
33.33%108.17M
Capital reserve funds
0.22%2.1B
2.42%2.14B
2.77%2.13B
3.18%2.13B
2.60%2.1B
3.03%2.09B
2.47%2.08B
1.74%2.06B
986.54%2.04B
983.21%2.03B
Surplus reserve funds
27.31%54.46M
27.31%54.46M
27.31%54.46M
27.31%54.46M
106.81%42.78M
106.81%42.78M
106.81%42.78M
106.81%42.78M
130.15%20.68M
130.15%20.68M
Retained profit
43.59%553.43M
79.96%545.98M
61.70%494.03M
64.24%444.22M
58.21%385.42M
65.41%303.39M
67.12%305.53M
65.63%270.47M
89.65%243.62M
74.93%183.42M
Less:Treasury stock
46.84%50M
--50M
--50M
--50M
--34.05M
----
----
----
----
----
Other composite income
-111.75%-133.94K
-123.57%-136.69K
---137.54K
---136.19K
---63.25K
---61.14K
----
----
----
----
Shareholders equity without minority interests
6.52%2.77B
10.04%2.8B
8.22%2.74B
8.12%2.68B
7.57%2.6B
8.69%2.54B
8.33%2.53B
7.10%2.48B
494.28%2.42B
512.45%2.34B
Minority interests
--371.49K
--450.99K
----
----
----
----
----
-88.44%-258.56K
-63.00%-166.87K
-172.65%-201.8K
Total shareholder equity
6.53%2.77B
10.06%2.8B
8.22%2.74B
8.13%2.68B
7.57%2.6B
8.70%2.54B
8.34%2.53B
7.10%2.48B
494.39%2.42B
512.52%2.34B
Total liabilityies and equity
10.39%3.76B
15.71%3.91B
18.13%3.83B
25.24%3.67B
25.10%3.41B
28.01%3.38B
24.05%3.25B
0.17%2.93B
202.45%2.72B
213.94%2.64B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -73.62%242.99M-42.96%615.45M-38.33%790.56M-28.81%881.93M-31.34%921.14M-28.91%1.08B-21.56%1.28B-38.46%1.24B751.41%1.34B1,658.25%1.52B
Transactional financial assets --219M--83.66M--------------------------------
Notes receivable and accounts receivable 93.97%396.77M77.38%357.94M31.03%252.88M40.39%213.2M78.90%204.55M138.22%201.79M91.45%193M96.69%151.87M70.73%114.34M40.44%84.71M
-Notes receivable -32.48%6.95M-21.23%3.96M0.24%4.46M464.54%13.28M219.44%10.3M23.32%5.03M304.29%4.45M416.01%2.35M-7.12%3.22M-33.95%4.08M
-Accounts receivable 100.67%389.82M79.90%353.98M31.75%248.42M33.71%199.92M74.82%194.25M144.04%196.76M89.10%188.55M94.79%149.52M74.98%111.12M48.93%80.63M
Other receivables (including interest and dividends) -41.41%3.17M-26.58%3.36M-35.88%3.16M-14.37%4.1M14.49%5.4M-9.09%4.57M-1.78%4.93M16.80%4.79M76.06%4.72M6.13%5.03M
-Other receivable -----26.58%3.36M-------------9.09%4.57M----16.80%4.79M----6.13%5.03M
Contractual assets 77.94%437.81M89.01%416.38M180.08%369.74M210.82%318.98M148.75%246.04M232.39%220.3M135.18%132.01M117.45%102.62M156.21%98.91M133.59%66.28M
Advance payment 32.70%66.92M17.76%42.95M42.72%53.52M76.44%42.28M89.55%50.43M87.85%36.47M120.10%37.5M80.98%23.96M103.54%26.6M376.32%19.42M
Inventories 70.23%149.22M67.65%152.32M63.15%123.75M41.06%93.17M58.36%87.66M119.55%90.85M144.53%75.85M189.04%66.05M77.85%55.35M360.37%41.38M
Other current assets 72.87%75.19M66.73%62.79M153.33%75.98M148.18%54.12M129.28%43.5M205.70%37.66M-32.94%29.99M-54.53%21.81M-26.99%18.97M-62.89%12.32M
Total current assets 2.08%1.59B3.84%1.73B-4.87%1.67B-0.13%1.61B-6.13%1.56B-4.37%1.67B-7.08%1.76B-27.66%1.61B394.18%1.66B610.13%1.75B
Non Current assets
Other non-current financial assets 2.06%132.35M16.32%132.35M39.09%125.51M48.55%120.51M577.21%129.69M620.13%113.78M1,403.94%90.24M1,522.45%81.12M283.00%19.15M216.00%15.8M
Long-term equity investment --17.57M--16.43M--16.52M--16.36M------------------------
Long term receivable account -----------------2.31%1.97M-2.21%1.95M-2.10%1.93M-1.99%1.91M4.34%2.02M4.52%2M
Fixed assets ----58.86%1.63B------------126.59%1.03B----16.75%521.61M----473.60%453.21M
Constru in process -----47.63%172.69M------------17.19%329.74M----424.80%546.21M-----18.76%281.37M
Intangible assets 14.30%91.88M29.39%104.83M13.58%92.78M11.78%92.07M21.17%80.39M21.02%81.02M20.69%81.69M35.50%82.37M8.27%66.34M8.76%66.94M
Long deferred expense -91.40%53.26K-9.14%359.66K-89.23%176.55K-93.82%246.59K-93.32%619.58K-96.44%395.85K-87.00%1.64M-72.31%3.99M-40.18%9.28M-23.65%11.13M
Deferred tax assets -2.21%63.8M-15.79%61.64M-18.36%52.43M-9.33%48.43M56.13%65.24M135.97%73.2M125.96%64.22M133.65%53.41M174.20%41.79M139.75%31.02M
Usufruct assets 4,971.75%3.48M803.35%990.85K-81.31%1.05M-85.03%1.14M-99.28%68.55K-99.05%109.69K-58.97%5.62M-51.87%7.6M-45.64%9.51M-41.94%11.6M
Other non current assets -17.17%65.71M-31.74%57.13M8.56%55.78M99.75%43.14M69.96%79.33M289.53%83.7M95.78%51.38M-19.77%21.6M76.93%46.68M-59.34%21.49M
Total non current assets 17.40%2.17B27.29%2.18B45.22%2.17B56.18%2.06B73.90%1.85B91.25%1.71B104.80%1.49B88.73%1.32B88.28%1.06B50.24%894.57M
Total assets 10.39%3.76B15.71%3.91B18.13%3.83B25.24%3.67B25.10%3.41B28.01%3.38B24.05%3.25B0.17%2.93B202.45%2.72B213.94%2.64B
Liabilities
Current liabilities
Short term loan 92.55%558.82M126.21%633.88M153.53%634.02M--369.32M--290.22M--280.21M--250.08M------------
Transactional financial liabilities --------------------------------------2.92M
Notes payable and accounts payable -44.85%132.21M-21.55%173.38M44.88%233.87M93.61%323.38M252.21%239.7M274.69%221M211.31%161.42M24.80%167.03M2.88%68.06M-50.31%58.98M
-Notes payable -80.74%17.61M-19.95%49.81M177.86%100.36M273.06%103.42M2,372.61%91.45M4,794.70%62.22M802.93%36.12M593.03%27.72M--3.7M--1.27M
-Accounts payable -22.70%114.6M-22.18%123.57M6.55%133.52M57.90%219.96M130.35%148.25M175.13%158.78M161.86%125.31M7.29%139.3M-2.71%64.36M-51.38%57.71M
Contract liabilities 2.40%92.73M14.32%90.8M-25.71%64.01M18.21%74.01M39.16%90.55M21.79%79.42M38.51%86.17M-12.02%62.61M-14.44%65.07M28.25%65.21M
Salaries payable -29.32%22.95M-8.37%22.88M29.57%22.04M53.82%64.51M61.10%32.47M41.85%24.97M54.48%17.01M75.29%41.94M61.67%20.15M50.84%17.61M
Taxs payable -66.69%9.25M-44.19%12.6M-26.07%7.86M29.01%12.09M78.43%27.75M754.38%22.58M310.63%10.63M10.49%9.37M1,332.43%15.55M147.49%2.64M
Other payable (including interest and dividends) 211.04%5.24M444.14%7.93M17.39%1.22M172.04%2.5M105.21%1.69M104.88%1.46M54.47%1.04M-20.84%918.15K106.04%821.71K-39.89%711.36K
-Other payable ----444.14%7.93M------------104.88%1.46M-----20.84%918.15K-----39.89%711.36K
Non current liabilities due within one year 297.49%706.87K120.57%392.25K-93.43%395.11K-95.65%384.69K-97.60%177.83K-98.12%177.83K-33.45%6.01M-96.14%8.84M--7.42M--9.44M
Total current liabilities 20.42%821.9M49.54%941.86M80.97%963.42M191.09%846.19M285.46%682.56M299.85%629.83M281.65%532.36M-38.50%290.7M13.39%177.08M-14.15%157.51M
Current liabilities
Long term loan --40.03M--40.02M-----------------------------80.93%39.25M
Estimate liabilities 16.67%91.39M-54.26%92.19M-48.78%89.47M-35.64%97.17M-37.65%78.33M101.21%201.53M85.18%174.66M75.90%150.97M121.12%125.64M101.77%100.16M
Deferred tax liabilities ----------------67,782.88%3.96M69,812.92%4.1M72,885.93%4.32M72,977.23%4.32M-1.39%5.83K-0.85%5.86K
Long term deferred income -18.42%33.43M2,596.73%37.01M2,697.47%39.5M2,701.79%40.67M--40.97M--1.37M--1.41M--1.45M--------
Lease liabilities --3.05M--848.81K382.92%913.49K--933.05K---------96.31%189.16K-----84.08%2.89M-82.20%3.6M
Total non current liabilities 36.21%167.9M-17.84%170.07M-28.07%129.88M-11.46%138.78M-4.10%123.27M44.74%207M29.78%180.58M16.62%156.74M-61.91%128.53M-48.13%143.01M
Total liabilities 22.83%989.8M32.87%1.11B53.35%1.09B120.13%984.97M163.68%805.82M178.45%836.83M155.88%712.94M-26.30%447.45M-38.08%305.61M-34.56%300.53M
Shareholders equity
Paid-in capital 0.98%109.23M0.70%108.92M0.70%108.92M0.70%108.92M0.00%108.17M0.00%108.17M0.00%108.17M0.00%108.17M33.33%108.17M33.33%108.17M
Capital reserve funds 0.22%2.1B2.42%2.14B2.77%2.13B3.18%2.13B2.60%2.1B3.03%2.09B2.47%2.08B1.74%2.06B986.54%2.04B983.21%2.03B
Surplus reserve funds 27.31%54.46M27.31%54.46M27.31%54.46M27.31%54.46M106.81%42.78M106.81%42.78M106.81%42.78M106.81%42.78M130.15%20.68M130.15%20.68M
Retained profit 43.59%553.43M79.96%545.98M61.70%494.03M64.24%444.22M58.21%385.42M65.41%303.39M67.12%305.53M65.63%270.47M89.65%243.62M74.93%183.42M
Less:Treasury stock 46.84%50M--50M--50M--50M--34.05M--------------------
Other composite income -111.75%-133.94K-123.57%-136.69K---137.54K---136.19K---63.25K---61.14K----------------
Shareholders equity without minority interests 6.52%2.77B10.04%2.8B8.22%2.74B8.12%2.68B7.57%2.6B8.69%2.54B8.33%2.53B7.10%2.48B494.28%2.42B512.45%2.34B
Minority interests --371.49K--450.99K---------------------88.44%-258.56K-63.00%-166.87K-172.65%-201.8K
Total shareholder equity 6.53%2.77B10.06%2.8B8.22%2.74B8.13%2.68B7.57%2.6B8.70%2.54B8.34%2.53B7.10%2.48B494.39%2.42B512.52%2.34B
Total liabilityies and equity 10.39%3.76B15.71%3.91B18.13%3.83B25.24%3.67B25.10%3.41B28.01%3.38B24.05%3.25B0.17%2.93B202.45%2.72B213.94%2.64B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Innovative Drugs
Innovative Drugs
Intraday+0.47%